tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Absci Corporation Advances AI-Driven Therapeutics
PremiumCompany AnnouncementsAbsci Corporation Advances AI-Driven Therapeutics
21d ago
Absci Reports Q3 Results, Focuses on ABS-201
Premium
Company Announcements
Absci Reports Q3 Results, Focuses on ABS-201
22d ago
Absci reports Q3 EPS (20c), consensus (21c)
Premium
The Fly
Absci reports Q3 EPS (20c), consensus (21c)
22d ago
Absci to host KOL seminar on ABS-201 androgenetic alopecia program
PremiumThe FlyAbsci to host KOL seminar on ABS-201 androgenetic alopecia program
2M ago
Absci participates in a conference call with JPMorgan
Premium
The Fly
Absci participates in a conference call with JPMorgan
2M ago
Promising Prospects for AbSci’s ABS-101: A Buy Rating Backed by Strong Pharmacology and Partnership Potential
Premium
Ratings
Promising Prospects for AbSci’s ABS-101: A Buy Rating Backed by Strong Pharmacology and Partnership Potential
2M ago
Absci Corp. Earnings Call: Strategic Gains Amid Challenges
PremiumCompany AnnouncementsAbsci Corp. Earnings Call: Strategic Gains Amid Challenges
3M ago
Promising Potential of AbSci’s ABS-201 Therapy for Androgenetic Alopecia: A Buy Recommendation
Premium
Ratings
Promising Potential of AbSci’s ABS-201 Therapy for Androgenetic Alopecia: A Buy Recommendation
4M ago
Promising Developments and Strong Financial Position Bolster AbSci’s Growth Prospects
Premium
Ratings
Promising Developments and Strong Financial Position Bolster AbSci’s Growth Prospects
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100